ACW 4.08% 5.1¢ actinogen medical limited

Ann: Ethics Approval Granted for Second Phase 1 Study of Xanamem

  1. lightbulb Created with Sketch. 851
    • Release Date: 16/02/15 09:37
    • Summary: Ethics Approval Granted for Second Phase 1 Study of Xanamem
    • Price Sensitive: Yes
    • Download Document    Not available as of the moment.
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
5.1¢
Change
0.00(4.08%)
Mkt cap $55.59M
Open High Low Value Volume
5.0¢ 5.1¢ 5.0¢ $7.068K 141.3K

Buyers (Bids)

No. Vol. Price($)
1 222640 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 30000 1
Last update - 15.14pm 19/10/2018 (20 minute delay) ?
(live)
Last
4.9¢
  Change
0.00 ( 0.00 %)
Open High   Low Volume
4.9¢ 5.0¢   4.9¢ 111054
Last updated 11.37am 19/10/2018 (live) ?
ACW (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.